Clinical Trial Update: A Study of the TAXUS Liberté Stent for the Treatment of Long De Novo Coronary Artery Lesions [Phase 3]

View source ↗

Summary

This document provides an update on a Phase 3 study evaluating the TAXUS Liberté paclitaxel-eluting stent for long de novo coronary artery lesions; the trial st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• TAXUS Liberté Stent (paclitaxel-eluting stent)

Snippet

Sponsor: Boston Scientific Corporation | Conditions: Coronary Artery Disease | Phase 3 | Status: COMPLETED